Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)
Data Columns
Download: Excel (XLSX), Comma-separated (CSV)
| Name | Description | Display Name | Data Type | Unit | Precision | Readout Type | Replicate | Comments |
|---|---|---|---|---|---|---|---|---|
| Einf | estimated maximal efficacy based on the asymptote of the curve used to fit relative cell counts for treatment versus control | Einf | Text | |||||
| EC50 | drug concentration producing half of its maximal effect, based on the curve used to fit relative cell counts for treatment versus control | EC50 | Text | uM |